CRB introduces its newest Horizons report,
exploring the life science industry in 2022 and beyond.

This is the third Horizons report in our life sciences series, and the first to invite North American, European, and multinational companies to share their perspectives with us. This maturing industry is in pursuit of more diversification, multimodal manufacturing, partnerships, and talent.